Epidemiology - The REACT Programme

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-273

Grant search

Key facts

  • Disease

  • Funder

    UK Research and Innovation (UKRI)
  • Principle Investigator

  • Research Location

    United Kingdom, Europe
  • Lead Research Institution

    UK Dementia Research Institute
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags


  • Study Subject


  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment


  • Age Group


  • Vulnerable Population


  • Occupations of Interest



The REACT programme, the largest of its kind, is a series of studies that are monitoring how the COVID-19 virus is spreading across England. Commissioned by the Department of Health and Social Care, the REACT series of studies are being carried out in partnership with Imperial College Healthcare NHS Trust and Ipsos MORI. The research is offering insight into infection rates broken down by geography, age, sex, ethnicity, key worker status and symptoms. REACT is the largest study of its kind and offers a comprehensive approach to antigen and antibody testing including a large sample (5000+) of keyworkers. REACT 1 and REACT 2 participants are to be followed up via NHS records. Patients who tested positive for COVID-19 (either antigen or antibody) will be followed up for neurological diseases via NHS records.